Dr. Linda Genen named CMO to further strengthen GeneDx’s commitment to delivering earlier answers and better outcomes through ...
AZoLifeSciences on MSN
LINE-1 retrotransposons reshape cancer genome architecture
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
Platform now available to pharmaceutical research partners; powers collaborations totaling over $200 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery ...
Sunish Sehgal, winter wheat breeder at South Dakota State University, explains the evolution of wheat and what can be ...
Researchers analyzed blood samples from polar bears located in northeastern and southeastern Greenland. The results showed that “some genes linked to heat-stress, aging and metabolism” were “behaving ...
A Viewpoint published in Genomic Psychiatry by Dr. Mayana Zatz and colleagues at the Human Genome and Stem Cell Research ...
Vietnam Investment Review on MSN
GenEditBio gets FDA clearance for in vivo genome editing programme
GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
The tool integrates de novo detection of NLR loci at the genome level with targeted genome reannotation, and systematically ...
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.
It’s Tuesday, Jan. 6, 2026, and today’s FSN Daily shifts from big-picture outlooks to the systems and science shaping food ...
AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...
Research shows how the curved shape of a zebrafish egg sets cell division timing, gene activation, and early cell fate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results